Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC
- Resource Type
- Article
- Authors
- Herbst, Roy S.; Garon, Edward B.; Kim, Dong-Wan; Cho, Byoung Chul; Gervais, Radj; Perez-Gracia, Jose L.; Han, Ji-Youn; Majem, Margarita; Forster, Martin D.; Monnet, Isabelle; Novello, Silvia; Gubens, Matthew A.; Boyer, Michael; Su, Wu-Chou; Samkari, Ayman; Jensen, Erin H.; Kobie, Julie; Piperdi, Bilal; Baas, Paul
- Source
- In Journal of Thoracic Oncology October 2021 16(10):1718-1732
- Subject
- Language
- ISSN
- 1556-0864